{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:25:26Z","timestamp":1787030726495,"version":"build-2736575974"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cerebral amyloid angiopathy (CAA) is a common age-associated cerebrovascular disease marked by amyloid-\u03b2 (A\u03b2) accumulation in cerebral vessel walls, and it is tightly linked to Alzheimer\u2019s disease (AD) and cognitive impairment. However, the specific mechanism in CAA progression remains poorly elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed 49 autopsy samples obtained from the Human Brain Bank of Hebei Medical University, collected basic pathological data and explored the correlations between CAA and Alzheimer\u2019s disease neuropathologic change (ADNC). Transcriptomic sequencing was performed on 21 occipital lobe specimens to screen differentially expressed genes underlying CAA and its pathological subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Neuropathological examination identified CAA pathology in 29 of 49 community donors (59.18%). Both CAA type and stage were significantly correlated with ADNC. In particular, CAA type 1 was closely associated with AD pathology and cognitive decline. Transcriptome analysis revealed that the GO functional enrichment was mainly concentrated in immune response-activating and -regulating signaling pathways. Triggering receptor expressed on myeloid cells 1 (\n                      <jats:italic>TREM1<\/jats:italic>\n                      ) gene was involved in the amplification of immune signals, and it was expressed more strongly in the CAA1 subtype.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      CAA is not simply an independent cerebrovascular disorder but also serves as a critical synergistic risk factor for ADNC progression.\n                      <jats:italic>TREM1<\/jats:italic>\n                      is a potential gene that could be associated with a more severe pathological progression of CAA1 type.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1933760","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:28:39Z","timestamp":1787027319000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["An analysis of cerebral amyloid angiopathy based on samples from human brain bank"],"prefix":"10.3389","volume":"17","author":[{"given":"Yizhou","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Human Anatomy, Human Brain Bank, Hebei Key Laboratory of Neurodegenerative Disease Mechanism, Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Human Brain Bank, Hebei Key Laboratory of Neurodegenerative Disease Mechanism, Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixiong","family":"Mi","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Human Brain Bank, Hebei Key Laboratory of Neurodegenerative Disease Mechanism, Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Human Brain Bank, Hebei Key Laboratory of Neurodegenerative Disease Mechanism, Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihan","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Human Brain Bank, Hebei Key Laboratory of Neurodegenerative Disease Mechanism, Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Human Brain Bank, Hebei Key Laboratory of Neurodegenerative Disease Mechanism, Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Human Brain Bank, Hebei Key Laboratory of Neurodegenerative Disease Mechanism, Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Human Brain Bank, Hebei Key Laboratory of Neurodegenerative Disease Mechanism, Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixian","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Human Brain Bank, Hebei Key Laboratory of Neurodegenerative Disease Mechanism, Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Human Brain Bank, Hebei Key Laboratory of Neurodegenerative Disease Mechanism, Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3988\/jcn.2011.7.1.1","article-title":"Cerebral amyloid angiopathy: a systematic review","volume":"7","author":"Biffi","year":"2011","journal-title":"J Clin Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-010-0652-7","article-title":"Vascular pathology in the aged human brain","volume":"119","author":"Grinberg","year":"2010","journal-title":"Acta Neuropathol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1017\/cbo9780511691836.005","article-title":"Cerebral amyloid angiopathy and Alzheimer\u2019s disease - one peptide, two pathways","volume":"16","author":"Greenberg","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/BF01181864","article-title":"Morphological diagnosis of vascular and senile dementia (the importance of cerebral congophilic angiopathy)","volume":"19","author":"Genisman","year":"1989","journal-title":"Neurosci Behav Physiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410240110","article-title":"Clinically diagnosed Alzheimer\u2019s disease: autopsy results in 150 cases","volume":"24","author":"Joachim","year":"1988","journal-title":"Ann Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-198512000-00003","article-title":"Postmortem evaluation of Alzheimer\u2019s disease","volume":"78","author":"Parker","year":"1985","journal-title":"South Med J"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000156522.93403.c3","article-title":"Role of cerebral amyloid angiopathy in intracerebral hemorrhage in hypertensive patients","volume":"64","author":"Ritter","year":"2005","journal-title":"Neurology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7247325","article-title":"The impact of cerebral amyloid angiopathy in various neurodegenerative dementia syndromes: a neuropathological study","volume":"2019","author":"De Reuck","year":"2019","journal-title":"Neurol Res Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.2011.01219.x","article-title":"Prevalence and severity of cerebral amyloid angiopathy: a population-based study on very elderly Finns (Vantaa 85+)","volume":"38","author":"Tanskanen","year":"2012","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1872-5","article-title":"Non-Alzheimer\u2019s contributions to dementia and cognitive resilience in The 90+ Study","volume":"136","author":"Robinson","year":"2018","journal-title":"Acta Neuropathol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200001273420403","article-title":"Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage","volume":"342","author":"O\u2019Donnell","year":"2000","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.5607\/en23014","article-title":"Advances in amyloid-\u03b2 clearance in the brain and periphery: implications for neurodegenerative diseases","volume":"32","author":"Ullah","year":"2023","journal-title":"Exp Neurobiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1159\/000148423","article-title":"Petite contribution a l\u2018etude d\u2019une angiopathie apparemment dyshorique et topistique","volume":"120","author":"Morel","year":"1950","journal-title":"Rev Mens Psychiatr Neurol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1258640","article-title":"Blood-brain barrier dysfunction and Alzheimer\u2019s disease: associations, pathogenic mechanisms, and therapeutic potential","volume":"15","author":"Chen","year":"2023","journal-title":"Front Aging Neurosci."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112903","article-title":"Dissecting the crosstalk between endothelial mitochondrial damage, vascular inflammation, and neurodegeneration in cerebral amyloid angiopathy and Alzheimer's disease","volume":"10","author":"Parodi-Rull\u00e1n","year":"2021","journal-title":"Cells"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3390\/cells13191624","article-title":"\u03b2-amyloids and immune responses associated with Alzheimer\u2019s disease","volume":"13","author":"Kolobova","year":"2024","journal-title":"Cells"},{"key":"B18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/glia.24105","article-title":"Microglia-specific ApoE knock-out does not alter Alzheimer\u2019s disease plaque pathogenesis or gene expression","volume":"70","author":"Henningfield","year":"2022","journal-title":"Glia"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-022-01240-0","article-title":"A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer's disease models","volume":"26","author":"van Lengerich","year":"2023","journal-title":"Nat Neurosci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11011-025-01631-9","article-title":"Microglial activation as a hallmark of neuroinflammation in Alzheimer\u2019s disease","volume":"40","author":"Ebrahimi","year":"2025","journal-title":"Metab Brain Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.37819\/hb.001.001.0209","article-title":"Standardized operational protocol for the China human brain bank consortium","volume":"1","author":"Wang","year":"2022","journal-title":"Hum Brain"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-018-0306-7","article-title":"Standardized operational protocol for human brain banking in China","volume":"35","author":"Qiu","year":"2018","journal-title":"Neurosci Bull"},{"key":"B23","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-008-0366-2","article-title":"Cerebral amyloid angiopathy and its relationship to Alzheimer\u2019s disease","volume":"115","author":"Thal","year":"2008","journal-title":"Acta Neuropathol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00401-015-1509-x","article-title":"Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy","volume":"131","author":"Kovacs","year":"2016","journal-title":"Acta Neuropathol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/conf.neuro.01.2009.16.123","article-title":"Argyrophilic grain disease","volume":"131","author":"Ferrer","year":"2008","journal-title":"Brain"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-022-02524-2","article-title":"LATE-NC staging in routine neuropathologic diagnosis: an update","volume":"145","author":"Nelson","year":"2023","journal-title":"Acta Neuropathol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-315813","article-title":"Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy","volume":"89","author":"Koga","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1037\/0894-4105.22.4.531","article-title":"The measurement of everyday cognition (ECog): scale development and psychometric properties","volume":"22","author":"Farias","year":"2008","journal-title":"Neuropsychology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neurobiolaging.2020.02.022","article-title":"Contribution of Alzheimer\u2019s disease neuropathologic change to the cognitive dysfunction in human brains with Lewy body-related pathology","volume":"91","author":"Zhang","year":"2020","journal-title":"Neurobiol Aging"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.70100","article-title":"Prevalence of cerebral amyloid angiopathy and its correlation with Alzheimer\u2019s disease and cognition in an autopsy-confirmed cohort from China","volume":"17","author":"Yin","year":"2025","journal-title":"Alzheimer\u2019s Dement (Amst)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9440(10)65616-7","article-title":"Perivascular drainage of amyloid- Peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer\u2019s disease","volume":"18","author":"Weller","year":"2008","journal-title":"Brain Pathol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262110386","article-title":"Triggering receptor expressed on myeloid cells-1 (TREM-1) in inflammation and disease: mechanisms, therapeutic potential, and future directions","volume":"26","author":"Trivedi","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.02.011","article-title":"Suppressing pro-inflammatory prostaglandin signaling attenuates excitotoxicity-associated neuronal inflammation and injury","volume":"149","author":"Jiang","year":"2019","journal-title":"Neuropharmacology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13024-025-00898-x","article-title":"Making tracks: microglia and the extracellular matrix","volume":"20","author":"Wareham","year":"2025","journal-title":"Mol Neurodegener"},{"key":"B38","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","article-title":"TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease","volume":"170","author":"Ulland","year":"2017","journal-title":"Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1933760\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:28:40Z","timestamp":1787027320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1933760\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2026.1933760"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1933760","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"article-number":"1933760"}}